Claim Details

View detailed information about this claim and its related sources.

Back to Claims

Claim Information

Complete details about this extracted claim.

Claim Text
The Food and Drug Administration’s investigational device program granted permission for the clinical trial, and company officials said they expected Paradromics would need to complete a larger trial before applying for F.D.A. approval of the device in several years.
Simplified Text
The FDA's investigational device program granted permission for the Paradromics clinical trial.
Confidence Score
1.000
Claim Maker
The author
Context Type
News Article
Context Details
{
    "action": "granted permission for clinical trial",
    "company": "Paradromics",
    "program": "investigational device program",
    "organization": "Food and Drug Administration"
}
UUID
4fab5895-8e6c-4b16-b2db-f2011dfe53d4
Vector Index
✗ No vector
Created
September 18, 2026 at 2:09 AM (3 weeks ago)
Last Updated
September 18, 2026 at 2:09 AM (3 weeks ago)

Original Sources for this Claim (1)

All source submissions that originally contained this claim.

Screenshot of https://nytimes.com/2026/09/14/well/brain-implant-helps-woman-communicate-in-real-time.html
https://nytimes.com/2026/09/14/well/brain-implant-helps-woman-communicate-in-real-time.html

A woman with a paralyzing disease used a wireless brain implant to converse in real time, even by just imagining words. This development by Paradromics marks a significant advance in brain-computer interfaces.

Similar Claims (5)

Other claims identified as semantically similar to this one.